AI applications  /  Tempus AI

{ai_tool.title} logo

Tempus AI

Precision medicineOncology

Tempus AI is a precision-medicine platform that combines genomic and clinical data with AI to personalize cancer treatments based on each patient's molecular profile.

Written by Claude Sonnet 4.6

What is Tempus AI?

Tempus AI is a precision-medicine platform that combines genomic and clinical data to tailor treatments to the individual patient. It analyzes the DNA of tumors in cancer patients, determines which mutations are present and links those findings to one of the largest oncology databases in the world to identify the most effective treatment options. In addition to oncology, Tempus is active in cardiology, neurology and infectious diseases.

How does Tempus AI work?

The technology combines next-generation sequencing of tumor DNA with multimodal AI models that integrate genomic, proteomic and clinical data. With more than 7 million de-identified patient profiles, machine learning algorithms recognize patterns in how specific mutations respond to certain treatments, based on real-world treatment outcomes. The sequencing takes place in CLIA-certified laboratories that meet clinical quality standards, after which physicians receive a report with treatment recommendations tailored to the molecular profile.

Key features

  • Genomic analysis — sequencing of tumor DNA to detect treatable mutations.
  • AI interpretation — multimodal models link mutations to effective therapies based on real-world evidence.
  • Treatment recommendations — reports with personalized options, including eligible clinical trials.
  • Broad dataset — more than 7 million patient profiles increase the statistical power of the models.
  • Multidisciplinary — applications within oncology, cardiology, neurology and infectious diseases.

Use cases and alternatives

For patients who do not respond to first-line treatment, genomic analysis offers a concrete route to personalized second-line or experimental therapy. Without this kind of platform, physicians spend a lot of time manually combing through literature to determine whether a mutation is treatable; Tempus automates that search step. Compared with providers such as Foundation Medicine or Guardant Health, Tempus stands out through the breadth of its data platform and the integration of clinical context alongside genetic data, rather than just sequencing as a service.

Who is it for?

Tempus AI is aimed at oncologists, genetic counselors and hospitals that want to implement precision medicine as standard care practice. Through its collaboration with large hospital systems and pharmaceutical companies, Tempus is also an infrastructure player in the development of new oncology therapies.


Ster Software

The most complete knowledge platform on artificial intelligence.

Kraaienjagersweg 24
7341 PT Beemte Broekland, Netherlands


© 2026 Ster Software BV · Chamber of Commerce 75474913

Content generated by Claude (Anthropic) · model: claude-sonnet-4-6